PanOptica takes in $11 mln Series B
New Jersey-based PanOptica Inc, a developer of ophthalmology therapies, has secured $11 million in Series B funding. The investors were Third Rock Ventures and SV Health Investors.
9 October 2017•1 min read
New Jersey-based PanOptica Inc, a developer of ophthalmology therapies, has secured $11 million in Series B funding. The investors were Third Rock Ventures and SV Health Investors.
